GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-13,900-16,235-21,436-20,027
Operating Activities, Cash Flows Provided By or Used In
Depreciation-178
Adjustments To Net Income4,7931,1462,4793,399
Changes In Accounts Receivables----
Changes In Liabilities-1,091-8122,419-342
Changes In Inventories----
Changes In Other Operating Activities198122-21
Total Cash Flow From Operating Activities-10,179-15,892-16,409-16,983
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures----
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities----
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings----
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities15,3793,5835,92513,701
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents5,200-12,309-10,484-3,282